Impact of Cause-Specific readmission on Long-Term mortality after transcatheter aortic valve implantation [0.03%]
经导管主动脉瓣植入术后不同再入院原因对长期预后的影响分析
Yoshitaka Naito,Arudo Hiraoka,Manami Himeno et al.
Yoshitaka Naito et al.
Background: Hospital readmissions after transcatheter aortic valve implantation (TAVI) are common, yet the long-term impact of both readmission for heart failure and non-cardiac readmissions, including infection, fracture...
Clinical implementation of 3D deep learning techniques in predicting touch-up lesions for atrial fibrillation patients undergoing cryoablation [0.03%]
用于冷冻消融心房颤动患者预测补救靶点的三维深度学习技术的临床应用
Chih-Min Liu,Wei-Wen Chen,Shih-Lin Chang et al.
Chih-Min Liu et al.
Background: Atrial fibrillation (AF) is a common heart rhythm disorder that can be treated with cryoballoon ablation (CBA). CBA occasionally requires additional radiofrequency-based touch-up ablation due to anatomical cha...
A prediction model for the risk of developing HFpEF during hospitalization in patients with acute myocardial infarction [0.03%]
急性心肌梗死患者住院期间发生HFpEF风险预测模型
Zhijie Liu,Yiming Fan,Yiting Su et al.
Zhijie Liu et al.
Aims: This study aimed to establish a clinical prediction model for evaluating the risk of heart failure (HF) with preserved ejection fraction (HFpEF) occurrence in patients with acute myocardial infarction (AMI). ...
D-dimer levels and outcomes in heart failure with mildly reduced ejection fraction [0.03%]
轻度射血分数降低型心力衰竭患者的D-二聚体水平与预后关系研究
Finn Kronberg,Tobias Schupp,Michael Behnes et al.
Finn Kronberg et al.
Objective: The study investigates the influence of D-dimer levels on the prognosis of patients hospitalized with heart failure with mildly reduced ejection fraction (HFmrEF). ...
Efficacy and safety of sodium-glucose cotransporter inhibitors in hypertrophic cardiomyopathy: a systematic review [0.03%]
钠-葡萄糖共转运蛋白抑制剂治疗肥厚型心肌病有效性和安全性的系统综述
Lorenzo Bianchi,Luisalice Afonso,Taras Chendey et al.
Lorenzo Bianchi et al.
Background: Sodium-Glucose Cotransporter inhibitors (SGLTi) are established therapies for heart failure (HF), chronic kidney disease, and type 2 diabetes. Their role in hypertrophic cardiomyopathy (HCM) remains undefined....
Determinants of cancer mortality in patients after acute myocardial infarction [0.03%]
心肌梗死后癌症死亡率的影响因素分析
David Scharlach,Timo Schmitz,Philip Raake et al.
David Scharlach et al.
Objective: To identify factors and preexisting conditions that are associated with overall cancer mortality, lung cancer mortality, and gastrointestinal cancer mortality in patients after acute myocardial infarction (AMI)...
Dual-chamber pacing for vasovagal syncope: A systematic review and meta-analysis of randomized controlled trials [0.03%]
双心室起搏治疗血管迷走性晕厥的系统评价和meta分析
Francesco Sbarra,Gianluca Pagnoni,Susan Darroudi et al.
Francesco Sbarra et al.
Introduction: Vasovagal syncope (VVS) is the most common cause of transient loss of consciousness and may be recurrent and disabling. Dual-chamber cardiac pacing has been proposed for patients with cardioinhibitory VVS, b...
Multi-site lactate kinetics during moderate intensity resistance and endurance exercise in definitive and probable arrhythmogenic cardiomyopathy [0.03%]
definite和probable致心律失常性心肌病患者中等强度阻力和耐力运动时多部位乳酸动力学反应的区别
Simon Wernhart,Marwin Shir,David Federle et al.
Simon Wernhart et al.
Distribution of lactate concentration across vascular sites and exercise. Comparison of rest and moderate intensity resistance and aerobic exercise: Lactate concentration differs across vascular sites. Handgrip (HG), bicep curl (BC), 20 (20...
Low-dose ventricular radiotherapy in wild-type transthyretin cardiac amyloidosis: a prospective, first-in-human, exploratory clinical trial [0.03%]
野生型转甲状腺素蛋白心肌淀粉样变性室壁低剂量放射治疗临床试验的可行性研究：一项针对人的前瞻性探索性临床试验
Damien Guijarro,Emmanuelle Massie,Thomas Zilli et al.
Damien Guijarro et al.
Background: Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA) causes heart failure through myocardial deposition of misfolded transthyretin (TTR) fibrils. Radiotherapy has been explored in localized amyloid depositi...
'A leukin to the future': is low serum interleukin-2 (IL-2) a predictive biomarker for postoperative atrial fibrillation? [0.03%]
低血清白细胞介素-2(IL-2)是术后房颤的预测性生物标志物吗？
Callum J Quinn,Epiphany S Velasco,Xander H T Wehrens
Callum J Quinn
The stubborn incidence of PoAF requires equally stubborn inroads to find novel regulatory proteins and/or trustworthy biomarkersz. This useful study by Cozac et al. [9] further establishes IL-2 as an important, yet poorly understood protein...